Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma

BACKGROUND AND PURPOSE: Pre-treatment ADC characteristics have been shown to predict response to bevacizumab in recurrent glioblastoma multiforme. However, no studies have examined whether ADC characteristics are specific to this particular treatment. The purpose of the current study was to determin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AJNR Am J Neuroradiol
Main Authors: Ellingson, B.M., Sahebjam, S., Kim, H.J., Pope, W.B., Harris, R.J., Woodworth, D.C., Lai, A., Nghiemphu, P.L., Mason, W.P., Cloughesy, T.F.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Neuroradiology 2014
Assuntos:
Brain
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7965805/
https://ncbi.nlm.nih.gov/pubmed/24136647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3748
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares